Càncer de mama triple negatiu; Autofàgia; Resistència terapèuticaCáncer de mama triple negativo; Autofagia; Resistencia terapéuticaTriple negative breast cancer; Autophagy; Therapeutic resistanceComment on: Wang RX, Xu XE, Huang L, et al. eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triplenegative breast cancer. Ann Transl Med 2019;7:783.None
Drug resistance in cancer cells is a frequent cause of breast cancer therapy failure. The aim of thi...
Resistance to EGFR-targeted therapy is a major obstacle on the road to effective treatment options f...
Breast cancer (BC) is the most commonly diagnosed cancer in women, constituting onethird of all canc...
Background: Breast cancer is accounted as the fifth leading cause of mortality among the other can-c...
Breast cancer is a heterogeneous disease consisting of different biological subtypes, with differenc...
T cell mediated therapies have proven largely unsuccessful in triple-negative breast cancer (TNBC). ...
Deregulation of the cell cycle machinery is a hallmark of cancer, leading to aberrant proliferation ...
International audienceThere is growing evidence for the role of cancer stem-cells in drug resistance...
While breast cancer patients benefit from the use of HER2 inhibitors, many fail therapy and become r...
Abstract Although great strides have been made over the decades in development and optimization of a...
Aquest és el primer informe que demostra que l'autofàgia està mecànicament vinculat al manteniment d...
Background:Triple negative breast cancer represents a significant treatment challenge due to its inh...
The rationale behind targeted molecular therapy in cancer, oncogene addiction, is that tumors rely o...
Autophagy, a lysosome-mediated degradation and recycling process that functions to promote stress ad...
PubMed ID: 31456180The term “autophagy”, which means “self (auto) - eating (phagy)”, describes a cat...
Drug resistance in cancer cells is a frequent cause of breast cancer therapy failure. The aim of thi...
Resistance to EGFR-targeted therapy is a major obstacle on the road to effective treatment options f...
Breast cancer (BC) is the most commonly diagnosed cancer in women, constituting onethird of all canc...
Background: Breast cancer is accounted as the fifth leading cause of mortality among the other can-c...
Breast cancer is a heterogeneous disease consisting of different biological subtypes, with differenc...
T cell mediated therapies have proven largely unsuccessful in triple-negative breast cancer (TNBC). ...
Deregulation of the cell cycle machinery is a hallmark of cancer, leading to aberrant proliferation ...
International audienceThere is growing evidence for the role of cancer stem-cells in drug resistance...
While breast cancer patients benefit from the use of HER2 inhibitors, many fail therapy and become r...
Abstract Although great strides have been made over the decades in development and optimization of a...
Aquest és el primer informe que demostra que l'autofàgia està mecànicament vinculat al manteniment d...
Background:Triple negative breast cancer represents a significant treatment challenge due to its inh...
The rationale behind targeted molecular therapy in cancer, oncogene addiction, is that tumors rely o...
Autophagy, a lysosome-mediated degradation and recycling process that functions to promote stress ad...
PubMed ID: 31456180The term “autophagy”, which means “self (auto) - eating (phagy)”, describes a cat...
Drug resistance in cancer cells is a frequent cause of breast cancer therapy failure. The aim of thi...
Resistance to EGFR-targeted therapy is a major obstacle on the road to effective treatment options f...
Breast cancer (BC) is the most commonly diagnosed cancer in women, constituting onethird of all canc...